|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61P 19/00 | |||
| C07K 16/24 |
| (11) | Number of the document | 1715891 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05702390.5 |
| Date of filing the European patent application | 2005-01-31 | |
| (97) | Date of publication of the European application | 2006-11-02 |
| (45) | Date of publication and mention of the grant of the patent | 2010-04-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2005/000240 |
| Date | 2005-01-31 |
| (87) | Number | WO 2005/080429 |
| Date | 2005-09-01 |
| (30) | Number | Date | Country code |
| 543814 P | 2004-02-11 | US |
| (72) |
BOVE, Susan, Elizabeth Pfizer Global Research &, US
KILGORE, Kenneth, Stanley Pfizer Global Research, US
|
| (73) |
Warner-Lambert Company LLC,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | METHODS OF TREATING OSTEOARTHRITIS WITH ANTI-IL-6 ANTIBODIES |
| METHODS OF TREATING OSTEOARTHRITIS WITH ANTI-IL-6 ANTIBODIES |